Protagon Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 08-01-2025
- Paid Up Capital ₹ 0.44 M
as on 08-01-2025
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.25 Cr
as on 08-01-2025
- Revenue -82.18%
(FY 2022)
- Profit -83.81%
(FY 2022)
- Ebitda -76.68%
(FY 2022)
- Net Worth 2.77%
(FY 2022)
- Total Assets -64.29%
(FY 2022)
About Protagon Biotech
The Corporate was formerly known as Agon Biotech Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.44 M.
The company has closed loans amounting to ₹1.25 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Narendra Gaba and Vatan Kumar serve as directors at the Company.
- CIN/LLPIN
U24200DL2012PTC233765
- Company No.
233765
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Mar 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Protagon Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narendra Gaba  | Director | 27-Jan-2015 | Current |
| Vatan Kumar | Director | 06-Nov-2023 | Current |
Financial Performance of Protagon Biotech.
Protagon Biotech Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 82.18% decrease. The company also saw a substantial fall in profitability, with a 83.81% decrease in profit. The company's net worth moved up by a moderate rise of 2.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Protagon Biotech?
In 2019, Protagon Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nvr Agritech Private LimitedActive 14 years 9 monthsNarendra Gaba and Vatan Kumar are mutual person
- Vat Solutions Private LimitedActive 22 years 4 months
Narendra Gaba and Vatan Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 29 Apr 2016 | ₹1.25 Cr | Satisfied |
How Many Employees Work at Protagon Biotech?
Unlock and access historical data on people associated with Protagon Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Protagon Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Protagon Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
